Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Lithuania Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20211
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Taiho Oncology, Inc.2
Takeda2
Celgene1
JaxBio Ltd1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes7
Anemia3
Leukemia, Myeloid, Acute3
Anemia, Refractory, with Excess of Blasts1
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia, Myelomonocytic, Chronic1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.